BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38503729)

  • 21. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
    Döhner H; Wei AH; Appelbaum FR; Craddock C; DiNardo CD; Dombret H; Ebert BL; Fenaux P; Godley LA; Hasserjian RP; Larson RA; Levine RL; Miyazaki Y; Niederwieser D; Ossenkoppele G; Röllig C; Sierra J; Stein EM; Tallman MS; Tien HF; Wang J; Wierzbowska A; Löwenberg B
    Blood; 2022 Sep; 140(12):1345-1377. PubMed ID: 35797463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
    Khoury JD; Solary E; Abla O; Akkari Y; Alaggio R; Apperley JF; Bejar R; Berti E; Busque L; Chan JKC; Chen W; Chen X; Chng WJ; Choi JK; Colmenero I; Coupland SE; Cross NCP; De Jong D; Elghetany MT; Takahashi E; Emile JF; Ferry J; Fogelstrand L; Fontenay M; Germing U; Gujral S; Haferlach T; Harrison C; Hodge JC; Hu S; Jansen JH; Kanagal-Shamanna R; Kantarjian HM; Kratz CP; Li XQ; Lim MS; Loeb K; Loghavi S; Marcogliese A; Meshinchi S; Michaels P; Naresh KN; Natkunam Y; Nejati R; Ott G; Padron E; Patel KP; Patkar N; Picarsic J; Platzbecker U; Roberts I; Schuh A; Sewell W; Siebert R; Tembhare P; Tyner J; Verstovsek S; Wang W; Wood B; Xiao W; Yeung C; Hochhaus A
    Leukemia; 2022 Jul; 36(7):1703-1719. PubMed ID: 35732831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.
    Liu B; Wang H
    Exp Ther Med; 2022 Jun; 23(6):394. PubMed ID: 35495610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel Promotes Oxidative Stress-Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin.
    Kumbul YÇ; Nazıroğlu M
    Biol Trace Elem Res; 2022 May; 200(5):2084-2098. PubMed ID: 35075596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells.
    Esparza-López J; Longoria O; De La Cruz-Escobar EN; Garibay-Díaz JC; León-Rodríguez E; De Jesús Ibarra-Sánchez M
    Oncol Lett; 2022 Feb; 23(2):50. PubMed ID: 34992683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in acute myeloid leukemia.
    Newell LF; Cook RJ
    BMJ; 2021 Oct; 375():n2026. PubMed ID: 34615640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell signaling pathways as molecular targets to eliminate AML stem cells.
    Rodrigues ACBDC; Costa RGA; Silva SLR; Dias IRSB; Dias RB; Bezerra DP
    Crit Rev Oncol Hematol; 2021 Apr; 160():103277. PubMed ID: 33716201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of leukaemia from pre-leukaemic and leukaemic stem cells.
    Shlush LI; Feldman T
    J Intern Med; 2021 May; 289(5):636-649. PubMed ID: 33511694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of FDA-approved acute myeloid leukemia therapies beyond '7 + 3'.
    Bazinet A; Assouline S
    Expert Rev Hematol; 2021 Feb; 14(2):185-197. PubMed ID: 33430671
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
    Stanchina M; Soong D; Zheng-Lin B; Watts JM; Taylor J
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33139625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Relapsed Acute Myeloid Leukemia.
    Thol F; Ganser A
    Curr Treat Options Oncol; 2020 Jun; 21(8):66. PubMed ID: 32601974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.
    Rawat L; Hegde H; Hoti SL; Nayak V
    Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting cancer stem cell pathways for cancer therapy.
    Yang L; Shi P; Zhao G; Xu J; Peng W; Zhang J; Zhang G; Wang X; Dong Z; Chen F; Cui H
    Signal Transduct Target Ther; 2020 Feb; 5(1):8. PubMed ID: 32296030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperlongumine Induces Cell Cycle Arrest via Reactive Oxygen Species Accumulation and IKKβ Suppression in Human Breast Cancer Cells.
    Jeong CH; Ryu H; Kim DH; Cheng WN; Yoon JE; Kang S; Han SG
    Antioxidants (Basel); 2019 Nov; 8(11):. PubMed ID: 31739520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.
    Winters AC; Gutman JA; Purev E; Nakic M; Tobin J; Chase S; Kaiser J; Lyle L; Boggs C; Halsema K; Schowinsky JT; Rosser J; Ewalt MD; Siegele B; Rana V; Schuster S; Abbott D; Stevens BM; Jordan CT; Smith C; Pollyea DA
    Blood Adv; 2019 Oct; 3(20):2911-2919. PubMed ID: 31648312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress.
    Chen W; Lian W; Yuan Y; Li M
    Cell Death Dis; 2019 Aug; 10(8):600. PubMed ID: 31395855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model.
    Baliza IRS; Silva SLR; Santos LS; Neto JHA; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Batista AA; Bezerra DP
    Front Oncol; 2019; 9():582. PubMed ID: 31334116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Products and Acute Myeloid Leukemia: A Review Highlighting Mechanisms of Action.
    Hwang D; Kim M; Park H; Jeong MI; Jung W; Kim B
    Nutrients; 2019 May; 11(5):. PubMed ID: 31058874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism.
    Yu W; Chen Y; Dubrulle J; Stossi F; Putluri V; Sreekumar A; Putluri N; Baluya D; Lai SY; Sandulache VC
    Sci Rep; 2018 Mar; 8(1):4306. PubMed ID: 29523854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
    Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
    Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.